“Rocket Lab Is BOOMING -- So Why Aren’t We Buying RKLB?”
AI summary · Rocket Lab stays on watch and is not a buy: record Q3 2026 revenue/backlog and a path toward a $2 billion business with Iridium are offset by a nearly $40 billion market cap, 25% share count growth and more Iridium dilution, plus debt refinancing that may need more stock. Neutron is delayed to 2027 and markets may already price Neutron/Iridium benefits, risking post-catalyst volatility; no good entry since March 2025, and they passed on the forty-four dollar dip.
Let's revisit Rocket Lab, the company that we have done a public video on a few times since early 2025, before the tariff tantrum. And, this report was gonna be an important one we knew because the company had already delayed the highly anticipated Neutron first launch into 2027.
Rocket Lab Q3 2026 earnings. Record revenue, record backlog. Yes, the Neutron first launch moves to 2027, sometime in 2027.